Recombinant protein expression systems have not changed fundamentally in 30 years. E. coli expression is cheap but yields non-glycosylated, sometimes misfolded proteins that require refolding optimization. HEK-293 and CHO mammalian cell systems produce properly glycosylated proteins but at significantly higher cost and batch variability. For growth factors and cytokines — where receptor binding affinity is directly coupled to glycosylation state and 3D structure — neither system is ideal.
MycoFold was built to solve this. Their platform uses engineered Komagataella phaffii (formerly Pichia pastoris) yeast as the expression chassis — a eukaryotic system that provides mammalian-type post-translational modifications, chaperoned folding for complete 3D protein structures, and consistent lot-to-lot performance that yeast fermentation enables by design. Combined with AI- and ML-guided sequence optimization to maximize receptor binding affinity, the result is a recombinant protein that outperforms both E. coli and HEK-293-based competitors in head-to-head activity assays.
The K. phaffii Expression Advantage
The choice of expression host is not a procurement detail — it determines what you get in the vial. MycoFold's technology platform combines three elements that together deliver a meaningfully different product:
Head-to-Head Performance Data
Scientific claims about recombinant protein quality need to be grounded in data. MycoFold benchmarks every product lot against the leading E. coli-expressed and HEK-293-expressed competitor versions using standardized bioassays calibrated against WHO or NIBSC international standards. The results are consistent.
As a concrete example: MycoFold's rHu M-CSF demonstrated a specific activity greater than 3.13 × 10⁵ IU/mg against the WHO Standard NIBSC 21/308, and outperformed both a leading E. coli-expressed and a leading HEK-293-expressed competitor version in dose-dependent induction of the M-NFS-60 cell line, as assessed by PrestoBlue™ Cell Viability luminescence assay.
Available Products: Growth Factors & Cytokines
MycoFold's current catalog focuses on human recombinant growth factors and cytokines — proteins where bioactivity, structural integrity, and lot consistency are most consequential to experimental outcome. All products ship lyophilized with a 24-month shelf life, ambient temperature shipping, and lot-specific CoA.
For immunology and drug discovery applications where cytokine bioactivity directly determines assay readout, the expression host is not a secondary specification — it is the experiment. A growth factor that induces 30% more proliferation per microgram is not just a better product; it changes the dose-response curve, the EC50 calculation, and the conclusion of any screen built around it.
Browse MycoFold Proteins on eBioHippo
AI-engineered growth factors and cytokines in ≥98% purity, with lot-specific CoA and 24-month shelf life.
View Protein Catalog → Compare Cytokines